Lv5
830 积分 2021-11-06 加入
ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
18小时前
待确认
Platelets in the crossfire of immune checkpoint therapy
1个月前
已关闭
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors
1个月前
已完结
Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma
1个月前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
10个月前
已完结
Radiotherapy toxicities: mechanisms, management, and future directions
10个月前
已完结
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
10个月前
已完结
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer
10个月前
已完结
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
1年前
已完结
皖公网安备34019202002308
